spacer
The Healthcare Sales & Marketing Network celebrates 28 years serving the medical sales & marketing community.Connecting Medical Sales Reps with MedTech/BioPharma Recruiters and Independent Reps with and New Product LinesConnecting Medical Sales Reps with MedTech/BioPharma Recruiters and Independent Reps with and New Product Lines

Searching News Database:  MMI 


 Your search returned too many results! The most recent 500 items are shown below:
 HSMN NewsFeed - 6 Aug 2026
Harbour BioMed Appoints Dr. Bob Zhang as President of Metabolic Disease Franchise to Accelerate Global Development of Innovative Therapies
Biopharmaceuticals Personnel
 HSMN NewsFeed - 4 Aug 2026
Galaxy Therapeutics Achieves CE Mark for SEAL(TM) Embolization System, Enabling Commercial Launch Across Europe and International Markets
Devices Neurology Interventional Regulatory
 HSMN NewsFeed - 29 Jul 2026
Spinal Elements Launches Luna(R) Ti
Devices Orthopaedic Neurosurgery Product Launch
 HSMN NewsFeed - 28 Jul 2026
BrainStorm Appoints Former FDA Associate Commissioner Peter J. Pitts as Executive Chairman
Regenerative Medicine Neurology Personnel
 HSMN NewsFeed - 27 Jul 2026
IceCure Medical Kicks Off its Post-Marketing "ChoICE" Study for the Low-Risk Breast Cancer Treatment at First U.S Clinical Site
Devices Oncology
 HSMN NewsFeed - 24 Jul 2026
Roche Receives FDA Clearance for the Cobas(R) BV/CV Assay, Enabling Fast and Highly Accurate Vaginitis Diagnosis
Diagnostics FDA
 HSMN NewsFeed - 22 Jul 2026
Mike Garrison to Retire from BD
Devices Personnel
 HSMN NewsFeed - 21 Jul 2026
Altesa BioSciences Welcomes Seasoned Biotech Leader Brett Haumann, MBBCh, MBA as Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 20 Jul 2026
Mentari Therapeutics Appoints Industry Veteran Greg Divis as Chief Executive Officer
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 16 Jul 2026
Lilly to Acquire AtaiBeckley to Advance Therapies for Treatment-Resistant Depression and Other Mental Health Conditions
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 14 Jul 2026
Zimmer Biomet Names Chintan Desai President of Asia Pacific Region
Devices Orthopaedic Personnel
 HSMN NewsFeed - 13 Jul 2026
Aethlon Medical Continues to Observe Directional Changes in Second Cohort of Australian Oncology Clinical Trial Evaluating Hemopurifier(R)
Devices Oncology
 HSMN NewsFeed - 7 Jul 2026
AtaCor Medical Announces First Patient Treated Globally in its ALARION-EV Pivotal Trial
Devices Cardiology
 HSMN NewsFeed - 6 Jul 2026
IceCure Highlights Expanding Commercial Adoption of ProSense(TM) Cryoablation in Brazil Following FDA Clearance for Breast Cancer
Devices Oncology
 HSMN NewsFeed - 2 Jul 2026
Spinogenix Appoints Professor Joseph T. Coyle, MD, Current Chair of Psychiatry and Neuroscience at Harvard Medical School, to Scientific Advisory Board
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 30 Jun 2026
Muna Therapeutics Announces CEO Transition as Clinical Pipeline Advances
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 29 Jun 2026
Theravance Biopharma Enters into Definite Agreement to be Acquired by Zymeworks for $17.00 Per Share in Cash Plus a Contingent Value Right
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 24 Jun 2026
ADC Therapeutics Announces Strategic Reorganization to Support ZYNLONTA(R) Growth Opportunities and Regulatory Priorities
Biopharmaceuticals Oncology
 HSMN NewsFeed - 23 Jun 2026
CereVasc, Inc. Completes Enrollment in STRIDE Pivotal Trial of the eShunt(R) System
Devices Neurosurgery
 HSMN NewsFeed - 15 Jun 2026
Celltaxis Names Co-Founder Eileen Heffernan as CEO to Accelerate Growth and Expand Leadership in Lymphatic Disease Therapeutics
Biopharmaceuticals Personnel
 HSMN NewsFeed - 11 Jun 2026
Viking Therapeutics Announces Appointment of Hubert C. Chen, M.D., as Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 10 Jun 2026
Subtle Medical Receives FDA Clearance for SubtleHD(TM)(CT), Expanding AI-Powered Image Enhancement into CT Imaging
Devices Radiology FDA
 HSMN NewsFeed - 8 Jun 2026
Protego Biopharma Appoints Jae B. Kim, MD, as Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 4 Jun 2026
CereVasc, Inc. Announces Over-Subscribed $85 Million Series C Financing to Advance its Novel eShunt(R) System for the Treatment of Normal Pressure Hydrocephalus
Devices Interventional Neurosurgery Venture Capital
 HSMN NewsFeed - 3 Jun 2026
Medtronic Announces Strategic Investments to Support Future Expansion of Cardiac Ablation Portfolio as Physician Demand for Affera(TM) Technologies Broadens
Devices Interventional Cardiology
 HSMN NewsFeed - 1 Jun 2026
Veritas Aortic Solutions, an inQB8 Spinout, Raises $12M to Advance Non-Surgical Treatment of Aortic Root and Ascending Aortic Diseases
Devices Interventional Cardiology Venture Capital
 HSMN NewsFeed - 28 May 2026
NOWDiagnostics Appoints Lisa Nibauer as Chief Executive Officer to Lead Next Phase of Innovation and Transformation
Diagnostics Personnel
 HSMN NewsFeed - 27 May 2026
Subtle Medical Receives FDA Clearance for SubtleHD(TM)(PET), Next-Generation AI-Powered Image Acceleration and Enhancement Software
Devices Radiology FDA
 HSMN NewsFeed - 26 May 2026
Olympus to Acquire BioProtect to Expand Its Portfolio of Urological Technologies and Address Prostate Cancer
Devices Urology Oncology Mergers & Acquisitions
 HSMN NewsFeed - 22 May 2026
AbbVie Announces Positive CHMP Opinion for MAVIRET(R) (glecaprevir/pibrentasvir) for the Treatment of Acute Hepatitis C Infection
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 19 May 2026
FRACTURE IDE trial of the Boston Scientific SEISMIQ(TM) 4CE Coronary Intravascular Lithotripsy Catheter Meets Primary Safety and Effectiveness Endpoints
Devices Interventional Cardiology
 HSMN NewsFeed - 14 May 2026
CREATE Medicines Announces $122 Million Series B Financing to Advance In Vivo CAR Pipeline in Autoimmune Disease and Oncology
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 12 May 2026
Bayesian Health Receives First-Ever FDA Clearance for Continuous AI Sepsis Monitoring
Devices Monitoring FDA
 HSMN NewsFeed - 11 May 2026
Partner Therapeutics Announces FDA Approval of BIZENGRI(R) (Zenocutuzumab-zbco) for NRG1 Fusion-Positive Cholangiocarcinoma Following Receipt of FDA Commissioner's National Priority Voucher
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 8 May 2026
Harbour BioMed Announces U.S. FDA IND Clearance for HBM7004 for the Treatment of Advanced Solid Tumors
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 6 May 2026
Cytora Ltd. Appoints Dr. Thomas Serena, MD, World Renowned Wound Care Expert to Scientific Advisory Board to Lead Patient Treatment Access and Data Collection for CytoraStem(TM) human Oral Mucosa Stem Cell (hOMSC) Therapy
Regenerative Medicine Wound Care Personnel
 HSMN NewsFeed - 5 May 2026
FX Shoulder Solutions, Inc. Receives FDA 510(k) Clearance for FX V135(R) Easytech Shoulder System
Devices Orthopaedic FDA
 HSMN NewsFeed - 4 May 2026
Olympus Signs Global Distribution Agreement with EndoRobotics, Adds Robot-Assisted Technologies to EndoTherapy Portfolio
Devices Distribution
 HSMN NewsFeed - 1 May 2026
Sonire Therapeutics Initiates First U.S. Clinical Study of Ultrasound-Guided HIFU Therapy for Pancreatic Cancer
Devices Oncology
 HSMN NewsFeed - 29 Apr 2026
BD Reimagines Central Line Insertion, Advancing Leadership in Patient Safety Through Breakthrough Vascular Access Technology
Devices Product Launch
 HSMN NewsFeed - 28 Apr 2026
Medtronic Announces CE Mark for Stealth AXiS(TM) Surgical System
Devices Surgery Regulatory
 HSMN NewsFeed - 27 Apr 2026
Lilly to Acquire Ajax Therapeutics to Advance Outcomes for Patients with Myelofibrosis and Polycythemia Vera
Biopharmaceuticals Oncology Mergers & Acquisitions
 HSMN NewsFeed - 24 Apr 2026
New Data Demonstrate Safety and Effectiveness of Bridge to Life's VitaSmart Hypothermic Oxygenated Machine Perfusion (HOPE) System in Partial Graft Pediatric Liver Transplantation
Devices Surgery
 HSMN NewsFeed - 23 Apr 2026
Atrium Therapeutics Earns $15 Million Milestone Payment from Bristol Myers Squibb Under Global Cardiovascular Collaboration
Biopharmaceuticals Licensing
 HSMN NewsFeed - 20 Apr 2026
Medtronic Completes Acquisition of CathWorks, Expanding its Leadership in Transforming Care for Patients with Cardiovascular Disease
Devices Interventional Cardiology Mergers & Acquisitions
 HSMN NewsFeed - 16 Apr 2026
Harbour BioMed Appoints Dr. Adam Zong as President
Biopharmaceuticals Personnel
 HSMN NewsFeed - 14 Apr 2026
Avanos Medical, Inc. Agrees To Be Acquired by American Industrial Partners for Approximately $1.272 Billion
Devices Mergers & Acquisitions
 HSMN NewsFeed - 13 Apr 2026
Lilly's Jaypirca (Pirtobrutinib) Significantly Extended Progression-Free Survival When Added to a Venetoclax Time-Limited Regimen in Patients with Previously Treated CLL/SLL
Biopharmaceuticals Oncology
 HSMN NewsFeed - 9 Apr 2026
Ziptek Introduces Breakthrough ZipE(R) Biolock(TM) Technology, Redefining Tissue Repair Worldwide
Devices Orthopaedic Surgery
 HSMN NewsFeed - 7 Apr 2026
When Every Beat Matters, BD Helps Clinicians Eliminate Blind Spots with Continuous, Noninvasive Blood Pressure Insight
Devices Monitoring
 HSMN NewsFeed - 6 Apr 2026
Neurocrine to Acquire Soleno Therapeutics, Expanding Its Endocrinology and Rare Disease Portfolio
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 2 Apr 2026
Zeto Announces FDA 510(k) Clearance of Zeto New Wave(TM), Advancing Efficiency in Outpatient EEG
Devices FDA
 HSMN NewsFeed - 1 Apr 2026
Nanoscope Therapeutics Appoints Ophthalmology Industry Veteran Paul Hallen as Chief Operating Officer to Advance Global Commercial Readiness
Biopharmaceuticals Ophthalmology Personnel
 HSMN NewsFeed - 31 Mar 2026
Lilly to Acquire Centessa Pharmaceuticals to Advance Treatments for Sleep-Wake Disorders
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 31 Mar 2026
SirPAD: Primary Results Confirm the Safety and Efficacy of Sirolimus Coated Balloon in PAD
Devices Interventional Cardiology
 HSMN NewsFeed - 30 Mar 2026
Boston Scientific receives FDA clearance for the Asurys(TM) Fluid Management System
Devices Surgery FDA
 HSMN NewsFeed - 27 Mar 2026
Otsuka Pharmaceutical to Acquire Transcend Therapeutics
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 23 Mar 2026
Viatris Advances Innovative Portfolio with Approval of Effexor(R) in Japan for Adults with Generalized Anxiety Disorder (GAD)
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 20 Mar 2026
Co-Diagnostics Signs Agreement to Significantly Expand Commercial and Distribution Territory Across South Asia
Diagnostics Distribution
 HSMN NewsFeed - 19 Mar 2026
Harbour BioMed Appoints Dr. Jenny Xie as Chief Scientific Officer, Immunology and Head of Global External Innovation
Biopharmaceuticals Personnel
 HSMN NewsFeed - 18 Mar 2026
Spinal Elements Expands Ventana(R) Platform with FDA 510(k) Clearance and First Cases of Ventana(R) A ALIF System
Devices Orthopaedic Neurosurgery FDA
 HSMN NewsFeed - 17 Mar 2026
VST BIO Corporation Announces Series A Financing to Advance VB-001 and Adds William Sessa to Board of Directors
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 12 Mar 2026
Ratio Therapeutics Appoints Global Medical Leader Colin Hayward as Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 11 Mar 2026
ARTHEx Biotech Granted FDA Fast Track Designation for ATX-01 for the Treatment of Myotonic Dystrophy Type 1 (DM1)
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 10 Mar 2026
Medtronic to Acquire Scientia Vascular, Marrying Access and Therapeutic Portfolios for Neurovascular Care
Devices Interventional Mergers & Acquisitions
 HSMN NewsFeed - 6 Mar 2026
U.S. FDA Approves TECVAYLI(R) in Combination with DARZALEX FASPRO(R) for Relapsed/Refractory Multiple Myeloma
Biopharmaceuticals Oncology Drug Delivery FDA
 HSMN NewsFeed - 5 Mar 2026
BD Advances Iliac Artery Treatment Across the European Union
Devices Interventional Regulatory
 HSMN NewsFeed - 4 Mar 2026
First-in-Human Use of CereVasc(R) eShunt(R) System in Idiopathic Intracranial Hypertension Demonstrates Sustained Clinical Outcomes
Devices Neurosurgery
 HSMN NewsFeed - 2 Mar 2026
Argo Biopharma Appoints Dr. Gena Wang as Chief Financial Officer and Chief Strategy Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 27 Feb 2026
Norgine Welcomes Positive CHMP Opinion Recommending Approval of Mavorixafor in the European Union for WHIM Syndrome
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 25 Feb 2026
Vanda Pharmaceuticals Announces FDA Acceptance of Biologics License Application Filing for Imsidolimab for the Treatment of Generalized Pustular Psoriasis
Biopharmaceuticals FDA
 HSMN NewsFeed - 23 Feb 2026
IDEAYA Biosciences Announces Appointment of Dr. Theodora (Theo) Ross, M.D., Ph.D., as Chief Development Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 20 Feb 2026
Brainstorm Cell Therapeutics Announces $1 Million Strategic Financing at Premium to Market
Regenerative Medicine Neurology Venture Capital
 HSMN NewsFeed - 19 Feb 2026
Altesa BioSciences Closes Oversubscribed $75 Million Series B Financing to Transform Treatment of Chronic Lung Diseases
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 18 Feb 2026
Mammotome Launches First In-Room MR Vacuum-Assisted Breast Biopsy System
Devices Product Launch
 HSMN NewsFeed - 17 Feb 2026
Medtronic Announces First Surgery With Hugo(TM) Robotic-Assisted Surgery System In the U.S. Performed at Cleveland Clinic
Devices Surgery
 HSMN NewsFeed - 12 Feb 2026
Bracco and ACIST Medical Systems Announce European Launch of ACIST Pro(TM) Diagnostic System
Diagnostics Interventional Product Launch
 HSMN NewsFeed - 11 Feb 2026
Labcorp Launches First FDA-Cleared Blood Test for Alzheimer's Disease Assessment in Primary Care
Diagnostics Neurology Product Launch
 HSMN NewsFeed - 10 Feb 2026
Vesalio Expands International Neurovascular Portfolio with CE Mark of NeVa VS and NeVa 3.0 mm and Receives Additional FDA 510(k) Clearance for its Aspiration Catheters
Devices Neurology Interventional Regulatory
 HSMN NewsFeed - 9 Feb 2026
Lilly to Acquire Orna Therapeutics to Advance Cell Therapies
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 29 Jan 2026
ViCentra Appoints Diabetes Commercialization Leader Reman McDonagh as Vice President, Global Marketing
Devices Endocrinology Personnel
 HSMN NewsFeed - 27 Jan 2026
Insilico Medicine and Qilu Pharmaceutical Reach Near $120 Million Drug Development Collaboration to Accelerate Novel Cardiometabolic Therapies
Biopharmaceuticals
 HSMN NewsFeed - 23 Jan 2026
Affera(TM) momentum continues as Medtronic announces CE Mark in Europe and U.S. IDE First Cases for Sphere-360™ PFA Catheter to Treat Paroxysmal Atrial Fibrillation
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 22 Jan 2026
Resolve M Therapeutics Exits From Stealth
Biopharmaceuticals
 HSMN NewsFeed - 19 Jan 2026
FDA Grants Regenerative Medicine Advanced Therapy (RMAT) Designation to iRegene's NouvNeu001, Making It the World's First iPSC Therapy with Both FTD and RMAT Recognitions
Regenerative Medicine Neurology FDA
 HSMN NewsFeed - 16 Jan 2026
Sobi Receives European Commission Approval for Aspaveli(R) (pegcetacoplan) for the Treatment of C3G and Primary IC-MPGN
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 15 Jan 2026
BD Receives FDA 510(k) Clearance for EnCor EnCompass(TM) Breast Biopsy and Tissue Removal System
Devices FDA
 HSMN NewsFeed - 15 Jan 2026
Boston Scientific announces agreement to acquire Penumbra, Inc.
Devices Interventional Mergers & Acquisitions
 HSMN NewsFeed - 14 Jan 2026
GT Medical Technologies Announces First Patients Treated with GammaTile in the BRIDGES Trial for Newly Diagnosed Glioblastoma
Devices Neurosurgery Oncology
 HSMN NewsFeed - 13 Jan 2026
MolecuLight Files ITC Complaint to Block Unlawful Importation of Infringing Fluorescence Bacteria Imaging Products
Devices Wound Care
 HSMN NewsFeed - 9 Jan 2026
Haemonetics Acquires Vivasure Medical Limited
Devices Interventional Mergers & Acquisitions
 HSMN NewsFeed - 8 Jan 2026
Saluda Medical Receives Regulatory Approval for EVA(TM) Sensing Technology in Europe with recognition in Australia
Devices Neurology Regulatory
 HSMN NewsFeed - 7 Jan 2026
Precision Redefined: LUMA Vision Completes VERAFEYE(TM) 4D-Guided Persistent AF Ablations, Demonstrating a Significant Advancement in Simplifying Image-Guided Cardiac Care
Devices Interventional Cardiology
 HSMN NewsFeed - 5 Jan 2026
BD Marks Milestone with First Phasix(TM) Hernia Prevention Case in Greece and Over 85% Enrollment in U.S. PREVENT Trial
Devices Surgery
 HSMN NewsFeed - 29 Dec 2025
FDA Accepts for Review INOVIO's BLA for INO-3107 for the Treatment of Adults with Recurrent Respiratory Papillomatosis (RRP)
Biopharmaceuticals FDA
 HSMN NewsFeed - 24 Dec 2025
Sanofi to Acquire Dynavax, Adding a Marketed Adult Hepatitis B Vaccine and Phase 1/2 Shingles Candidate to the Pipeline
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 23 Dec 2025
Zydus Partners with Bioeq for U.S. Commercialisation rights for NUFYMCO(R), an Interchangeable Biosimilar to Lucentis(R)
Biopharmaceuticals Licensing
 HSMN NewsFeed - 19 Dec 2025
BioMarin to Acquire Amicus Therapeutics for $4.8 Billion, Expanding Position as a Leader in Rare Diseases, Accelerating Revenue Growth and Strengthening Financial Outlook
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 18 Dec 2025
BD and Penn Institute for Immunology and Immune Health Collaborate to Advance Immunotherapy through Flow Cytometry
Diagnostics
 HSMN NewsFeed - 17 Dec 2025
GT Medical Technologies Welcomes New GammaTile(R) Center of Excellence Program Designation
Devices Neurosurgery Oncology
 HSMN NewsFeed - 16 Dec 2025
Zimmer Biomet, OneStep Collaborate to Provide Enhanced Mobility Data to Patients and Surgeons to Help Improve Joint Procedure Recovery
Devices Orthopaedic
 HSMN NewsFeed - 15 Dec 2025
Sobi to Acquire Arthrosi Therapeutics, Strengthening Pipeline for the Potential Treatment of Gout
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 11 Dec 2025
Skil-Care Corporation(TM) Announces New Partnership with Capstone Health Alliance as a Contracted Supplier Partner
Devices Distribution
 HSMN NewsFeed - 11 Dec 2025
NexGen Hyperbaric Expands National Presence to Florida, Adds New Professional Sports Customer, and Announces Flagship Facility Launch
Devices
 HSMN NewsFeed - 9 Dec 2025
Mercury Bio Announces Appointment of Casey Perkins as Vice President of Corporate Strategy & Business Development
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 5 Dec 2025
Olympus, Gore, and ConMed Announce Transition of Commercial Support for the GORE(R) VIABIL(R) Biliary Endoprosthesis in the United States
Devices Distribution
 HSMN NewsFeed - 4 Dec 2025
SciNeuro Pharmaceuticals Announces $53 Million Financing to Further Advance Pipeline of Therapies for Neurodegenerative Diseases and Appointment of Chief Financial Officer
Biopharmaceuticals Neurology Venture Capital
 HSMN NewsFeed - 3 Dec 2025
Shoulder Innovations Announces Strategic Partnership with INS to Introduce a Robotic Platform for Shoulder Arthroplasty
Devices Orthopaedic
 HSMN NewsFeed - 1 Dec 2025
Morphocell Technologies Completes US$50 Million Series A Financing
Regenerative Medicine Venture Capital
 HSMN NewsFeed - 28 Nov 2025
Vanda Pharmaceuticals Provides Regulatory Update on Tradipitant for Motion Sickness
Biopharmaceuticals FDA
 HSMN NewsFeed - 26 Nov 2025
Restore Medical Appoints Former Medtronic Executive Chris Cleary as Chairman of the Board
Devices Cardiology Personnel
 HSMN NewsFeed - 24 Nov 2025
Hollister Incorporated Drives Major Policy Change to Expand Access to Closed System Intermittent Catheters for People with Spinal Cord Injuries
Devices Urology Regulatory
 HSMN NewsFeed - 18 Nov 2025
Piccolo Medical(R) Receives FDA Clearance to Expand ECGuide(TM) Technology Use to Pediatric and Neonatal Patients
Devices FDA
 HSMN NewsFeed - 17 Nov 2025
BD Onclarity(TM) HPV Assay for BD COR(TM) and BD Viper(TM) LT Systems Receive WHO Prequalification
Diagnostics Regulatory
 HSMN NewsFeed - 14 Nov 2025
Zimmer Biomet Receives U.S. FDA Clearance for Enhanced Version of ROSA(R) Knee Robotic Technology
Devices Orthopaedic FDA
 HSMN NewsFeed - 13 Nov 2025
icotec Receives FDA Clearance for the CMORE(R) CT System, Expanding its BlackArmor(R) Engineered Carbon/PEEK Technology to the Posterior Cervicothoracic Spine
Devices Orthopaedic Neurosurgery FDA
 HSMN NewsFeed - 12 Nov 2025
BD Expands PureWick(TM) Portfolio with First-of-its-Kind Portable Solution to Confidently Manage Urinary Incontinence On the Go
Devices Urology Product Launch
 HSMN NewsFeed - 10 Nov 2025
Par Health Completes Spin-Off from Mallinckrodt, Creating an Independent Leader in Generic Pharmaceuticals and Sterile Injectables
Biopharmaceuticals Generics Mergers & Acquisitions
 HSMN NewsFeed - 7 Nov 2025
Laborie Announces Agreement to Acquire the JADA(R) System from Organon
Devices Acquisitions
 HSMN NewsFeed - 7 Nov 2025
Gore Announces Positive Clinical Trial Results of the Investigational Gore(R) Viabahn(R) Fortegra Venous Stent for Treatment of Patients With Deep Venous Iliocaval Obstruction
Devices Interventional
 HSMN NewsFeed - 6 Nov 2025
GT Medical Technologies Welcomes New GammaTile(R) Center of Excellence Program Designation
Devices Neurosurgery Oncology
 HSMN NewsFeed - 6 Nov 2025
Amber Implants Appoints Vincent Gardès as Chief Executive Officer to Drive Commercial Launch of VCFix(R) Spinal System
Devices Orthopaedic Neurosurgery Personnel
 HSMN NewsFeed - 5 Nov 2025
Volta Medical Brings Volta AF-Xplorer(TM) II to the U.S., Ushering in a New Era of AI in Ablation for Complex Atrial Fibrillation
Devices Interventional Cardiology Product Launch
 HSMN NewsFeed - 5 Nov 2025
Braveheart Bio Launches with $185M Series A Aiming to Transform Care of Hypertrophic Cardiomyopathy
Biopharmaceuticals Cardiology Venture Capital
 HSMN NewsFeed - 4 Nov 2025
Ratio Therapeutics Announces the Appointment of Marcel Reichen as Chief Strategy Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 3 Nov 2025
Alcresta Therapeutics Announces FDA Clearance for Expanded Use of RELiZORB(R) (iMMOBILIZED LIPASE) Cartridge for Neonates and Infants
Biopharmaceuticals FDA
 HSMN NewsFeed - 30 Oct 2025
Brenig Therapeutics Names Megan McGill as Chief Executive Officer
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 28 Oct 2025
Zimmer Biomet Announces FDA Breakthrough Designation for World's First Iodine-Treated Total Hip Replacement System
Devices Orthopaedic FDA
 HSMN NewsFeed - 28 Oct 2025
ViCentra Strengthens Leadership Team to Accelerate Growth
Devices Endocrinology Drug Delivery Personnel
 HSMN NewsFeed - 27 Oct 2025
Remedy Robotics and Mission Thrombectomy Announce Partnership to Expand Access to Thrombectomy for Stroke with Telerobotics
Devices Interventional Neurology
 HSMN NewsFeed - 27 Oct 2025
Hemab Therapeutics Announces $157 Million Series C Financing to Advance Next-Generation Treatments for Underserved Bleeding Disorders
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 24 Oct 2025
Terumo Interventional Systems Announces Its New OPUSWAVE(R) Dual Sensor Imaging System and DualView(R) Imaging Catheter Receive FDA 510(k) Clearance
Devices Interventional Cardiology FDA
 HSMN NewsFeed - 23 Oct 2025
Labcorp to Offer First FDA-Cleared Blood Test to Rule out Alzheimer's-Related Amyloid Pathology in Primary Care Settings
Diagnostics Neurology
 HSMN NewsFeed - 21 Oct 2025
Onkos Surgical(R) Receives FDA 510(k) Clearance for ELEOS(TM) Proximal Tibia with NanoCept(R) Antibacterial Technology
Devices Orthopaedic FDA
 HSMN NewsFeed - 21 Oct 2025
PleoPharma, Inc. Closes $36 Million Series B Financing Round
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 20 Oct 2025
GRAIL, Inc. Announces $325.0 Million Private Placement Financing
Diagnostics Oncology Venture Capital
 HSMN NewsFeed - 17 Oct 2025
Boston Scientific Announces Agreement to Acquire Nalu Medical, Inc.
Devices Neurology Mergers & Acquisitions
 HSMN NewsFeed - 16 Oct 2025
Calico Appoints Philip R. Kym, Ph.D., as Head of Drug Discovery
Biopharmaceuticals Personnel
 HSMN NewsFeed - 15 Oct 2025
CAPS Medical's PlasmaSure(TM) Receives FDA Breakthrough Device Designation
Devices Oncology FDA
 HSMN NewsFeed - 14 Oct 2025
Atossa Appoints Mark Daniel, CPA, as Chief Financial Officer to Lead Finance, Systems, and Capital Strategy for Commercial Readiness
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 9 Oct 2025
Leap Therapeutics Announces Closing of $58.88 Million Private Placement in Cash Led by Winklevoss Capital to Initiate a Digital Asset Treasury Strategy
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 9 Oct 2025
BD Reaches Major Milestone for Rotarex(TM) Catheter System with First Patient Enrolled in XTRACT(TM) Registry to Advance Real-World Evidence in Peripheral Artery Disease
Devices Interventional
 HSMN NewsFeed - 8 Oct 2025
Medtronic Initiates U.S. IDE Clinical Study Evaluating Hugo(TM) Robotic-Assisted Surgery System for Gynecological Procedures
Devices Surgery
 HSMN NewsFeed - 8 Oct 2025
Lumen Bioscience Expands Board and Leadership Team to Advance Clinical Pipeline of Novel Oral Biologics
Biopharmaceuticals Personnel
 HSMN NewsFeed - 7 Oct 2025
Cardinal Health Launches a New All-In-One Solution for Deep Vein Thrombosis and Pulmonary Embolism Prevention
Devices Product Launch
 HSMN NewsFeed - 6 Oct 2025
Olympus and W. L. Gore & Associates Enter into International Distribution Agreement to Expand the Olympus EndoTherapy Portfolio
Devices Interventional Distribution
 HSMN NewsFeed - 2 Oct 2025
OncoC4 Closes Nearly $50 Million in Series B Financing to Advance Multiple Pipeline Candidates
Biopharmaceuticals Oncology Neurology Venture Capital
 HSMN NewsFeed - 1 Oct 2025
Revance Expands Leadership Team with Key Executive Appointments
Devices Dermatology Personnel
 HSMN NewsFeed - 26 Sep 2025
Accuray Launches All-in-One Radiotherapy Solution With Advanced Capabilities Designed to Set a New Standard in Cancer Care
Devices Oncology Product Launch
 HSMN NewsFeed - 24 Sep 2025
TSC Life Receives FDA 510(K) Clearance for Fluido(R) AirGuard System, a Moderate to High Flow Blood and IV Fluid Warming Solution for the Prevention of Hypothermia
Devices FDA
 HSMN NewsFeed - 22 Sep 2025
Mallinckrodt Names Dr. Marek J. Honczarenko as EVP and Chief Scientific Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 18 Sep 2025
J & D Pharmaceuticals LLC Receives Orphan Drug Designation for Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Biopharmaceuticals FDA
 HSMN NewsFeed - 16 Sep 2025
Roche Receives CE Mark for Accu-Chek SmartGuide Continuous Glucose Monitoring and mySugr App Integration, Offering an Enhanced Diabetes Management Experience
Devices Monitoring Regulatory
 HSMN NewsFeed - 12 Sep 2025
B. Braun Acquires True Digital Surgery
Devices Surgery Mergers & Acquisitions
 HSMN NewsFeed - 5 Sep 2025
Roche Receives CE IVDR Approval for HER2 (4B5) Companion Diagnostic Test to Identify HER2-ultralow Breast Cancer and Biliary Tract Cancer Patients
Diagnostics Oncology Regulatory
 HSMN NewsFeed - 3 Sep 2025
Terumo Neuro Unveils New SOFIA(TM) Flow 88 Neurovascular Aspiration Catheter Data from EMEA Demonstrating Strong Performance
Devices Interventional Neurology
 HSMN NewsFeed - 3 Sep 2025
Terumo Neuro Launches Aneurysm Treatment Alliance in EMEA to Advance Physician Collaboration and Aneurysm Care
Devices Interventional Neurology
 HSMN NewsFeed - 2 Sep 2025
Servier and IDEAYA Biosciences Partner to Bring Darovasertib, a Promising Uveal Melanoma Treatment, to Patients Worldwide
Biopharmaceuticals Oncology Licensing
 HSMN NewsFeed - 28 Aug 2025
Zimmer Biomet Announces New Chief Medical Advisors to Help Improve Standard of Musculoskeletal Care
Devices Orthopaedic Personnel
 HSMN NewsFeed - 27 Aug 2025
Leal Therapeutics Announces $30 Million Series A to Progress First-In-Class Neuro-Metabolic Therapies for Neurodegenerative and Neuropsychiatric Disorders with High-Unmet Need
Biopharmaceuticals Neurology Venture Capital
 HSMN NewsFeed - 25 Aug 2025
Akeso Reports Phase 3 Trials Show Positive Results: Gumokimab (IL-17) for Ankylosing Spondylitis and Manfidokimab (IL-4R?) for Atopic Dermatitis Achieve Primary Endpoints
Biopharmaceuticals
 HSMN NewsFeed - 22 Aug 2025
Sonic Healthcare USA, Inc. Announces Acquisition of Cairo Diagnostics LLC to Expand Sonic's National Hematology Oncology Testing Capabilities
Diagnostics Oncology Mergers & Acquisitions
 HSMN NewsFeed - 20 Aug 2025
Anne White to Retire as Executive Vice President and President, Lilly Neuroscience
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 20 Aug 2025
CytoSorbents Updates U.S. FDA Regulatory Status of DrugSorb-ATR
Devices FDA
 HSMN NewsFeed - 19 Aug 2025
Medtronic Announces Board Appointments and Shareholder Value Creation Initiatives to Advance Strategic Priorities
Devices Personnel
 HSMN NewsFeed - 15 Aug 2025
Precigen Announces Full FDA Approval of PAPZIMEOS (zopapogene imadenovec-drba), the First and Only Approved Therapy for the Treatment of Adults with Recurrent Respiratory Papillomatosis
Biopharmaceuticals FDA
 HSMN NewsFeed - 14 Aug 2025
Superluminal Medicines Announces Collaboration with Eli Lilly and Company to Advance Small Molecule Therapeutics for Cardiometabolic Diseases and Obesity
Biopharmaceuticals
 HSMN NewsFeed - 11 Aug 2025
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Granted FDA Fast Track Designation for NRX-100 for Suicidal Ideation in Patients with Depression, including Bipolar Depression
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 7 Aug 2025
ulrich medical USA(R) Announces Full Market Launch of Cortium(R) Universal OCT Spinal Fixation System
Devices Orthopaedic Neurosurgery Product Launch
 HSMN NewsFeed - 6 Aug 2025
Mallinckrodt Names Christiana Stamoulis as President and Chief Financial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 5 Aug 2025
Hemispherian Receives FDA IND Clearance for First-in-Class Glioblastoma Therapeutic, GLIX1
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 5 Aug 2025
Instylla Appoints MedTech Leader Sean Boyle as Chief Executive Officer
Devices Interventional Personnel
 HSMN NewsFeed - 4 Aug 2025
OrbiMed Raises $1.86 Billion for Healthcare Royalty & Credit Fund V
Devices Biopharmaceuticals Diagnostics Venture Capital
 HSMN NewsFeed - 1 Aug 2025
BioMarin Announces Appointment of Ian T. Clark to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 31 Jul 2025
Ultromics Lands $55M Series C to Tackle Undiagnosed Heart Failure at Scale
Devices Cardiology Venture Capital
 HSMN NewsFeed - 30 Jul 2025
BD Receives FDA 510(k) Clearance for Rapid Point-of-Care COVID-19 Test
Diagnostics FDA
 HSMN NewsFeed - 30 Jul 2025
MAGENTIQ EYE Secures Series A Investment Led by aMoon to Drive the Future of AI-Powered Gastroenterology
Devices Gastroenterology Venture Capital
 HSMN NewsFeed - 28 Jul 2025
MapLight Therapeutics Announces $372.5 Million Series D Financing
Biopharmaceuticals Neurology Venture Capital
 HSMN NewsFeed - 28 Jul 2025
Embolx Launches Sniper G3: Revolutionizing Embolization with Enhanced Efficiency, Ease of Use, and Extended Shelf Life
Devices Interventional Product Launch
 HSMN NewsFeed - 24 Jul 2025
GT Medical Technologies Welcomes New GammaTile(R) Center of Excellence Program Designation
Devices Oncology Neurosurgery
 HSMN NewsFeed - 23 Jul 2025
Neuros Medical Announces First Commercial Implant of the Altius(R) Direct Electrical Nerve Stimulation System, a Breakthrough Non-Opioid Treatment for Chronic Post-Amputation Pain
Devices Neurology FDA
 HSMN NewsFeed - 23 Jul 2025
BD Announces First Pharma-Sponsored Clinical Trial Using BD Libertas(TM) Wearable Injector Technology for Biologic Drugs
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 22 Jul 2025
SPRITAM(R) (levetiracetam) Tablets for Oral Suspension Approved by FDA for Nasogastric and Gastrostomy Tube Administration
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 22 Jul 2025
Centinel Spine(R) prodisc(R) Total Disc Replacement Grows 47% Worldwide in Second Quarter 2025, Setting New Revenue Record
Devices Orthopaedic Neurosurgery
 HSMN NewsFeed - 21 Jul 2025
AKSM/Oncology Selects RayCare and RayStation For a New Cancer Center
Devices Oncology
 HSMN NewsFeed - 18 Jul 2025
B. Braun Expands Heparin Sodium Injection Portfolio to Seven Heparin Premixed Sodium Injection Products
Biopharmaceuticals Drug Delivery Product Launch
 HSMN NewsFeed - 17 Jul 2025
Saluda Medical Announces Full U.S. Launch of EVA(TM) Sensing Technology for Use with the Evoke(R) SmartLoop(TM) System
Devices Neurology Product Launch
 HSMN NewsFeed - 16 Jul 2025
Piccolo Medical, Inc. Receives FDA Clearance for 2nd Generation SmartPICC(R) Technology
Devices FDA
 HSMN NewsFeed - 15 Jul 2025
GT Medical Technologies Completes Final Close of Company's Oversubscribed $53 Million Series D Equity Financing to Advance Commercial Treatment for Patients with Operable Brain Tumors
Devices Neurosurgery Oncology Venture Capital
 HSMN NewsFeed - 14 Jul 2025
Zimmer Biomet Announces Definitive Agreement to Acquire Monogram Technologies, Expanding Robotics Suite with Autonomous Solutions
Devices Orthopaedic Mergers & Acquisitions
 HSMN NewsFeed - 14 Jul 2025
Illimis Therapeutics Closes 58 billion KRW ($42 million) Series B Financing to accelerate CNS and Immune Disease Drug Development via GAIA Platform
Biopharmaceuticals Neurology Venture Capital
 HSMN NewsFeed - 10 Jul 2025
Klotho Neurosciences, Inc. Granted FDA Orphan Drug Designation for KLTO-202 for Treatment of Amyotrophic Lateral Sclerosis ("ALS" or "Lou Gehrig's Disease")
Regenerative Medicine Neurology FDA
 HSMN NewsFeed - 9 Jul 2025
Neuros Medical Secures $56M Series D to Commercialize the Altius(R) System, an FDA-Approved, Non-Opioid Nerve Stimulation System for Chronic Post-Amputation Pain
Devices Venture Capital
 HSMN NewsFeed - 8 Jul 2025
Soligenix Corporate Update Letter - Key Highlights and Upcoming Milestones
Biopharmaceuticals Oncology
 HSMN NewsFeed - 7 Jul 2025
Boston Scientific Receives FDA Approval for Expanded Labeling of FARAPULSE(TM) Pulsed Field Ablation System
Devices Interventional Cardiology FDA
 HSMN NewsFeed - 3 Jul 2025
Novartis Provides Update on Phase III GCAptAIN Study of Cosentyx(R) in Giant Cell Arteritis (GCA)
Biopharmaceuticals
 HSMN NewsFeed - 2 Jul 2025
Moon Surgical Receives FDA Clearance for Maestro(TM) Connectivity and Predetermined Change Control Plan for AI-Powered ScoPilot(R)
Devices Surgery FDA
 HSMN NewsFeed - 30 Jun 2025
Oncolytics Biotech(R) Appoints Former Ambrx Executive as Chief Business Officer to Drive Business Development Strategy
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 27 Jun 2025
RaySearch Releases RayCare v2025
Devices Oncology Product Launch
 HSMN NewsFeed - 25 Jun 2025
Viking Therapeutics Announces Initiation of Phase 3 Obesity Clinical Program with GLP-1/GIP Agonist VK2735
Biopharmaceuticals Endocrinology
 HSMN NewsFeed - 24 Jun 2025
Ascidian Therapeutics Appoints Dr. Murray A. Abramson as Chief Development Officer and Establishes Ophthalmology Clinical Advisory Board to Advance ACDN-01 for Treatment of Stargardt Disease
Biopharmaceuticals Ophthalmology Personnel
 HSMN NewsFeed - 23 Jun 2025
Sephience(TM) (sepiapterin) Granted Marketing Authorization by the European Commission for the Treatment of Children and Adults Living with Phenylketonuria (PKU)
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 20 Jun 2025
Lomond Therapeutics Announces U.S. FDA Clearance of IND Application for Lonitoclax, a Selective BCL2 Inhibitor with Limited Immune Suppression and Improved Safety Compared to Venetoclax and Venetoclax- Like Molecules
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 19 Jun 2025
Johnson & Johnson Launches VOLT(TM) Wrist and Proximal Humerus Plating Systems in the U.S.
Devices Orthopaedic Product Launch
 HSMN NewsFeed - 17 Jun 2025
Corvia Medical Closes $55 Million Funding Round to Complete Confirmatory Trial and Pursue FDA Approval of Corvia Atrial Shunt
Devices Cardiology Venture Capital
 HSMN NewsFeed - 16 Jun 2025
Solu Therapeutics Appoints Enda Moran, PhD, MBA as Chief Operating Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 12 Jun 2025
Medtronic Announces MiniMed as Name for Planned New Diabetes Company
Devices Endocrinology Mergers & Acquisitions
 HSMN NewsFeed - 11 Jun 2025
SpliceBio Secures $135 Million Series B Financing to Advance Lead Program SB-007 in Stargardt Disease and Expand Pipeline of Genetic Medicines
Regenerative Medicine Ophthalmology Venture Capital
 HSMN NewsFeed - 6 Jun 2025
Hemispherian Receives Positive Opinion for Orphan Medicinal Product Designation in the EU for GLIX1 in Glioma
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 5 Jun 2025
Penumbra Introduces the Ruby(R) XL System - the Longest, Largest, and Softest Coil on the Market for Vascular Embolization
Devices Interventional FDA Product Launch
 HSMN NewsFeed - 5 Jun 2025
Spineart Announces Full-Market Launch of SCARLET(R) AC-Ti Secured Anterior Cervical Cage in the US
Devices Orthopaedic Neurosurgery Product Launch
 HSMN NewsFeed - 4 Jun 2025
Cardinal Health Launches New Medical Device for the Continuous Monitoring of Three Essential Vital Signs in One System
Devices Monitoring Product Launch
 HSMN NewsFeed - 3 Jun 2025
Amber Implants Announces Successful One-Year Follow-Up Data in First-in-Human Clinical Trial of VCFix(R) Spinal System
Devices Orthopaedic Neurosurgery
 HSMN NewsFeed - 2 Jun 2025
Sanofi to Acquire Blueprint Medicines, Expanding Portfolio in Rare Immunological Disease and Adding Early-stage Pipeline in Immunology
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 30 May 2025
Isotopia and Cardirad Announce Launch of Isoprotrace(R) in Sweden and Denmark, Expanding Access to Advanced Prostate Cancer Imaging
Biopharmaceuticals Radiology Oncology Product Launch
 HSMN NewsFeed - 28 May 2025
BD to Initiate Real-World Patient Data Registry for the Rotarex(TM) Atherectomy System in Treatment of Peripheral Artery Disease
Devices Interventional
 HSMN NewsFeed - 27 May 2025
BrainStorm Secures Key Manufacturing Partnership with Minaris for Upcoming NurOwn(R) Phase 3b ALS Clinical Trials
Regenerative Medicine Neurology
 HSMN NewsFeed - 22 May 2025
ulrich medical USA(R) Appoints Eric Gibbs as President and General Manager
Devices Orthopaedic Neurosurgery Personnel
 HSMN NewsFeed - 21 May 2025
Medtronic Announces Intent to Separate Diabetes Business
Devices Endocrinology Drug Delivery
 HSMN NewsFeed - 20 May 2025
Ritedose Pharmaceuticals Receives FDA Approval for Albuterol Sulfate Inhalation Solution, 0.5% (2.5 mg/0.5 mL)*--Addressing Nationwide Shortage of the Essential Drug
Biopharmaceuticals FDA
 HSMN NewsFeed - 16 May 2025
BioMarin Strengthens Enzyme Therapy Business with Acquisition of Inozyme Pharma
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 16 May 2025
Neutron Therapeutics and Helsinki University Hospital Treat First Head and Neck Cancer Patients Using Accelerator-Based Boron Neutron Capture Therapy
Devices Oncology
 HSMN NewsFeed - 15 May 2025
Alpheus Medical Raises $52M in Series B Round to Advance Groundbreaking Glioblastoma Therapy
Devices Oncology Venture Capital
 HSMN NewsFeed - 14 May 2025
GT Medical Technologies Welcomes New GammaTile(R) Center of Excellence Program Designation
Devices Neurosurgery Oncology
 HSMN NewsFeed - 13 May 2025
Hansa Biopharma appoints Maria Törnsén as Chief Operating Officer and President U.S.
Biopharmaceuticals Personnel
 HSMN NewsFeed - 9 May 2025
FDA Approves Teal Health's Teal Wand(TM)--The First and Only At-Home Self-Collection Device for Cervical Cancer Screening, Introducing a Comfortable Alternative to In-Person Screening
Devices Diagnostics FDA
 HSMN NewsFeed - 8 May 2025
Lilly Announces Transitions in Executive Leadership
Biopharmaceuticals Personnel
 HSMN NewsFeed - 7 May 2025
PAQ Therapeutics Announces $39 Million Series B Financing and Initiates Phase 1 Trial to Advance Novel Approach Addressing KRAS-Driven Cancers with High Unmet Need
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 5 May 2025
Spinogenix Announces FDA-Authorized Expanded Access Program for SPG302, the First Synaptic Regenerative Therapy to Treat ALS
Biopharmaceuticals Regenerative Medicine Neurology FDA
 HSMN NewsFeed - 2 May 2025
RaySearch releases RayStation v2025
Devices Oncology Product Launch
 HSMN NewsFeed - 1 May 2025
Altesa BioSciences announces Katharine Knobil, M.D. as Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 30 Apr 2025
Regulus Therapeutics Enters into Agreement to be Acquired by Novartis AG
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 24 Apr 2025
Medtronic Advances Abbott CGM Partnership with FDA Submission of Interoperable Insulin Pump
Devices Endocrinology FDA
 HSMN NewsFeed - 23 Apr 2025
Boston Scientific Chief Financial Officer (CFO) Dan Brennan to Retire; Jon Monson, Senior Vice President, Investor Relations to Succeed Brennan
Devices Personnel
 HSMN NewsFeed - 21 Apr 2025
BD Launches Next Generation Hemodynamic Monitoring Solution Providing Clinicians with AI-Driven Clinical Decision Support
Devices Monitoring Product Launch
 HSMN NewsFeed - 18 Apr 2025
Leidos Invests $10 Million in AI Disease Detection with University of Pittsburgh
Diagnostics
 HSMN NewsFeed - 17 Apr 2025
MAP Medical Launches as Innovative Medical Supply Concierge
Devices Distribution Product Launch
 HSMN NewsFeed - 16 Apr 2025
Xtant Medical Announces Secondary Private Sale of Existing Shares by OrbiMed and Preliminary First Quarter 2025 Revenue Growth of 18% to 19%
Devices Orthopaedic Wound Care Venture Capital
 HSMN NewsFeed - 14 Apr 2025
Viatris Appoints Hemanth J. Varghese as Chief Strategy Officer
Biopharmaceuticals Generics Personnel
 HSMN NewsFeed - 11 Apr 2025
Turbett Surgical Receives FDA 510(k) Clearance for Enhanced Instrument Pod Portfolio
Devices Surgery FDA
 HSMN NewsFeed - 10 Apr 2025
BrainStorm Cell Therapeutics Submits IND Amendment to FDA, Paving the Way for Phase 3b Trial of NurOwn(R) in ALS
Regenerative Medicine Neurology FDA
 HSMN NewsFeed - 9 Apr 2025
Solu Therapeutics Closes $41M Series A Financing and Announces First Patient Dosed in Phase 1 Clinical Trial of STX-0712 in Patients with CMML and Other Advanced Hematologic Malignancies
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 7 Apr 2025
ICU Medical Introduces Its New Category of Infusion Devices With FDA Clearances of Plum Solo(TM) and Plum Duo(TM) Precision IV Pumps
Devices Drug Delivery FDA
 HSMN NewsFeed - 4 Apr 2025
Neurocrine Biosciences Appoints Dr. Sanjay Keswani as Chief Medical Officer
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 2 Apr 2025
Append Medical Appoints Shlomi Nachman as Chairman of the Board
Devices Interventional Cardiology Personnel
 HSMN NewsFeed - 31 Mar 2025
Orna Therapeutics Appoints Joseph Bolen, Ph.D., as Chief Executive Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 31 Mar 2025
Lomond Therapeutics Completes Second and Third Closings and adds Two New Investors
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 27 Mar 2025
Pharmaceutical Industry Veteran, Ashish Patel, PhD, Joins Nanoscope as Senior Vice President of Sales and Marketing
Regenerative Medicine Ophthalmology Personnel
 HSMN NewsFeed - 25 Mar 2025
Hubble Therapeutics Closes Series A Financing to Develop Gene Therapy Cure for LCA16
Biopharmaceuticals Ophthalmology Venture Capital
 HSMN NewsFeed - 24 Mar 2025
Newronika Receives CE Mark Approval for AlphaDBS, Advancing Adaptive Deep Brain Stimulation for Parkinson's Disease
Devices Neurology Regulatory
 HSMN NewsFeed - 21 Mar 2025
Accuryn Medical Announces Leadership Transition With Appointment of Todd Dunn as CEO
Devices Monitoring Personnel
 HSMN NewsFeed - 20 Mar 2025
Bristol Myers Squibb Appoints Osama Braiwish as General Manager for Saudi Arabia & Gulf Countries
Biopharmaceuticals Personnel
 HSMN NewsFeed - 19 Mar 2025
Terumo Neuro Celebrates 15 Years of the WEB(TM) Device: A Game-Changing Innovation in Aneurysm Treatment
Devices Interventional Neurology
 HSMN NewsFeed - 17 Mar 2025
Latigo Biotherapeutics Closes $150 Million in Series B Financing to Advance Non-Opioid Pain Therapeutics
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 13 Mar 2025
Mallinckrodt and Endo to Combine to Create a Global, Scaled, Diversified Pharmaceuticals Leader
Biopharmaceuticals Generics Mergers & Acquisitions
 HSMN NewsFeed - 7 Mar 2025
Zimmer Biomet Receives FDA Clearance for Persona(R) Revision SoluTion(TM) Femur
Devices Orthopaedic FDA
 HSMN NewsFeed - 5 Mar 2025
Jazz Pharmaceuticals to Acquire Chimerix, Further Diversifying Oncology Portfolio
Biopharmaceuticals Oncology Mergers & Acquisitions
 HSMN NewsFeed - 4 Mar 2025
Nervonik Raises $13 Million in Series A Financing to Advance Next-Generation Peripheral Nerve Stimulation for Chronic Pain Relief
Devices Neurology Venture Capital
 HSMN NewsFeed - 3 Mar 2025
Boston Scientific Announces Agreement to Acquire SoniVie Ltd.
Devices Cardiology Mergers & Acquisitions
 HSMN NewsFeed - 28 Feb 2025
RFA For Life Announces New American Medical Association CPT(R) Codes for Thyroid Nodule Radiofrequency Ablation (RFA)
Devices Oncology Reimbursement
 HSMN NewsFeed - 27 Feb 2025
Indivior Announces Joseph Ciaffoni Appointed Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 26 Feb 2025
ABANZA Receives FDA 510(k) Clearance for WasherCap(TM) Mini Implantable Fixation Device
Devices Orthopaedic FDA
 HSMN NewsFeed - 21 Feb 2025
FDA Declares Wegovy(R) and Ozempic(R) Shortage is Over and that Novo Nordisk is Fully Meeting or Exceeding Nationwide Demand for All Doses
Biopharmaceuticals FDA
 HSMN NewsFeed - 20 Feb 2025
Valencia Technologies Announces Strategic Investment of up to $35 Million and Appointment of James D. Surek as Chief Executive Officer
Devices Personnel Venture Capital
 HSMN NewsFeed - 18 Feb 2025
Oncolytics Biotech(R) Strengthens Its Pipeline in 2025 with Key Pancreatic and Anal Cancer Advances in Addition to Metastatic Breast Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 14 Feb 2025
AbbVie Appoints CEO Robert A. Michael as Chairman of the Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 13 Feb 2025
Roche Elecsys sFlt-1/PlGF Ratio for Preeclampsia Receives FDA 510(k) Clearance, Offering a Fast and Raliable Way to Predict the Risk of Developing Severe Preeclampsia
Diagnostics FDA
 HSMN NewsFeed - 12 Feb 2025
AbbVie and Xilio Therapeutics Announce Collaboration and Option Agreement to Develop Novel Tumor-Activated Immunotherapies
Biopharmaceuticals Oncology Licensing
 HSMN NewsFeed - 11 Feb 2025
Neuvotion Receives FDA Clearance for NeuStim(TM) Providing Non-Invasive, High-Resolution Stimulation for the Hand After Stroke or Spinal Cord Injury
Devices Neurology FDA
 HSMN NewsFeed - 10 Feb 2025
Nektar Therapeutics Receives Fast Track Designation for Rezpegaldesleukin for the Treatment of Moderate-to-Severe Atopic Dermatitis
Biopharmaceuticals Dermatology FDA
 HSMN NewsFeed - 7 Feb 2025
Most Patients on Lilly's Omvoh(R) (mirikizumab-mrkz) for Crohn's Disease Achieved Sustained Clinical Remission and Endoscopic Response at Two Years
Biopharmaceuticals Gastroenterology
 HSMN NewsFeed - 6 Feb 2025
Accuryn Medical Welcomes Business Innovation Leader to Support Team in Transforming Kidney Care
Devices Monitoring Personnel
 HSMN NewsFeed - 5 Feb 2025
Newronika Receives Investigational Device Exemption (IDE) from FDA to Initiate U.S. Clinical Trial of Adaptive DBS System
Devices Neurology FDA
 HSMN NewsFeed - 4 Feb 2025
MedRhythms Hires Joel Behnke as Chief Commercial Officer; Announces New Publications in Support of InTandem(R)
Devices Neurology Personnel
 HSMN NewsFeed - 3 Feb 2025
CHMP Issues Positive Opinion for Subcutaneous RYBREVANT(R)(amivantamab) Co-Formulated with ENHANZE(R) for the Treatment of Patients with Advanced EGFR-Mutated Non-Small Cell Lung Cancer
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 31 Jan 2025
U.S. FDA Approves Celltrion's AVTOZMA(R) (tocilizumab-anoh), a Biosimilar to ACTEMRA(R)
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 30 Jan 2025
Coeptis Therapeutics Holdings Becomes COEPTIS: Embracing a Future of Technology and Innovation
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 24 Jan 2025
Nuevocor Welcomes Andreas Wallnöfer as Chairman of the Board of Directors
Regenerative Medicine Cardiology Personnel
 HSMN NewsFeed - 23 Jan 2025
Vantis Vascular Announces Superior Clinical Performance of the Crossfast Advanced Delivery System in First Commercial Cases
Devices Interventional Cardiology Product Launch
 HSMN NewsFeed - 22 Jan 2025
Shotel(TM) Medical Expansion Signals Growing Demand for Its Ankle Arthrodesis Device
Devices Orthopaedic Distribution
 HSMN NewsFeed - 21 Jan 2025
Medtronic appoints Thierry Piéton as Chief Financial Officer
Devices Personnel
 HSMN NewsFeed - 20 Jan 2025
MicroAire Completes Acquisition of NEOSYAD
Devices Mergers & Acquisitions
 HSMN NewsFeed - 17 Jan 2025
FDA Approves LUMAKRAS(R) (Sotorasib) in Combination with Vectibix(R) (Panitumumab) for Chemorefractory KRAS G12C-Mutated Metastatic Colorectal Cancer
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 15 Jan 2025
New Drug Application Initiated with U.S. FDA for TAR-200, the First and Only Intravesical Drug Releasing System for Patients with BCG-Unresponsive High-Risk Non-Muscle-Invasive Bladder Cancer
Biopharmaceuticals Drug Delivery Oncology FDA
 HSMN NewsFeed - 14 Jan 2025
LUMA Vision Successfully Completes First-in-Human Procedures with its Novel VERAFEYE(TM) Navigation and Visualization Platform
Devices Interventional Cardiology
 HSMN NewsFeed - 13 Jan 2025
Medtronic Achieves CE Mark Approval for BrainSense Adaptive Deep Brain Stimulation and Electrode Identifier, a Groundbreaking Advance In Personalized, Sensing-Enabled Care for People with Parkinson's Through Innovative Brain-Computer Interface Technology
Devices Neurosurgery Regulatory
 HSMN NewsFeed - 13 Jan 2025
Roche receives FDA clearance for new, highly-sensitive test to aid clinicians in diagnosing B-cell lymphoma
Diagnostics Oncology FDA
 HSMN NewsFeed - 8 Jan 2025
Johnson & Johnson's Posdinemab and Tau Active Immunotherapy Receive U.S. FDA Fast Track Designations for the Treatment of Alzheimer's Disease
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 3 Jan 2025
The Mayo Clinic, the leading US hospital, will test Nevisense in Pilot
Devices Dermatology
 HSMN NewsFeed - 2 Jan 2025
Movano Health Welcomes Dr. Shaheen Wirk to its Board of Directors
Devices Monitoring Personnel
 HSMN NewsFeed - 31 Dec 2024
Kazia Therapeutics Provides Update on Paxalisib Regulatory Pathway Following Type C Meeting with FDA
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 30 Dec 2024
Halozyme Announces FDA Approval of Bristol Myers Squibb's Opdivo Qvantig(TM) with ENHANZE(R) for Subcutaneous Use in Most Previously Approved Adult Solid Tumor Opdivo(R) (nivolumab) Indications
Biopharmaceuticals Drug Delivery Oncology FDA
 HSMN NewsFeed - 26 Dec 2024
Coeptis Therapeutics Makes Bold Strides in Innovation with the Acquisition of NexGenAI Affiliates Network Platform and Launch of Coeptis Technologies
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 23 Dec 2024
Traws Pharma Announces Progress in Developing Tivoxavir Marboxil for H5N1 Bird Flu
Biopharmaceuticals
 HSMN NewsFeed - 20 Dec 2024
Neurocrine Biosciences Announces Commercial Availability of CRENESSITY(TM) (crinecerfont) for Children and Adults With Classic Congenital Adrenal Hyperplasia
Biopharmaceuticals Product Launch
 HSMN NewsFeed - 19 Dec 2024
Astellas and Sangamo Therapeutics Announce Capsid License Agreement to Deliver Genomic Medicines for Neurological Diseases
Biopharmaceuticals Neurology Licensing
 HSMN NewsFeed - 18 Dec 2024
New Data Indicates the CyberKnife(R) System Can Provide a Safe and Effective Treatment Option to Control Brainstem Metastases, an Extremely Challenging Location to Treat
Devices Oncology Neurosurgery
 HSMN NewsFeed - 17 Dec 2024
BD and Babson Diagnostics Launch Innovative Fingertip Blood Testing to Health Care Organizations
Diagnostics Product Launch
 HSMN NewsFeed - 13 Dec 2024
Zimmer Biomet Receives FDA Clearance for OsseoFit(TM) Stemless Shoulder System for Total Shoulder Replacement
Devices Orthopaedic FDA
 HSMN NewsFeed - 12 Dec 2024
U.S. FDA Expands Indication for Impella Heart Pumps to Treat Pediatric Patients
Devices Cardiology FDA
 HSMN NewsFeed - 3 Dec 2024
Terumo Interventional Systems Announces Launch of Its R2P NaviCross Peripheral Support Catheter
Devices Interventional Product Launch
 HSMN NewsFeed - 2 Dec 2024
Mallinckrodt Completes Divestiture of Therakos(R) Business
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 26 Nov 2024
Poseida Therapeutics, Inc. Announces Agreement to be Acquired by Roche Holdings, Inc.
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 25 Nov 2024
LifeSignals Receives FDA 510(k) Approval for UbiqVue(TM) 2A Multiparameter System
Devices Monitoring FDA
 HSMN NewsFeed - 22 Nov 2024
U.S. FDA Approves StemCyte Biologics License Application for REGENECYTE(TM) Cord Blood Cell Therapy Product
Biopharmaceuticals FDA
 HSMN NewsFeed - 21 Nov 2024
SOPHiA GENETICS Launches MSK-IMPACT(R) powered with SOPHiA DDM(TM) at AMP 2024
Diagnostics Product Launch
 HSMN NewsFeed - 20 Nov 2024
Medtronic Receives FDA Clearance for New InPen(TM) App, Paving the Way for its Smart MDI System Launch with Simplera(TM) CGM
Devices Monitoring FDA
 HSMN NewsFeed - 18 Nov 2024
Zimmer Biomet Announces CE Mark Certification for Persona(R) Revision Knee System
Devices Orthopaedic Regulatory
 HSMN NewsFeed - 18 Nov 2024
IDEAYA Biosciences Appoints Stu Dorman as Chief Commercial Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 15 Nov 2024
Boston Scientific Closes Acquisition of Axonics, Inc.
Devices Mergers & Acquisitions
 HSMN NewsFeed - 14 Nov 2024
Stryker Launches Next Generation of SurgiCount+ to Help Improve the Standard of Care in Hospitals for Sponge Management and Blood Loss Assessment
Devices Surgery Product Launch
 HSMN NewsFeed - 13 Nov 2024
Zimmer Biomet Welcomes Arnold Schwarzenegger as Chief Movement Officer
Devices Orthopaedic Personnel
 HSMN NewsFeed - 13 Nov 2024
SmartCardia Receives FDA Clearance for Outpatient Cardiac Telemetry for Its 7-Lead ECG Patch and Cloud Platform
Devices Monitoring Cardiology FDA
 HSMN NewsFeed - 12 Nov 2024
Nevro's HFX iQ(TM) Spinal Cord Stimulation with AI Technology Receives CE Mark Certification in Europe, Increasing Product Expansion Globally
Devices Regulatory
 HSMN NewsFeed - 11 Nov 2024
Momentis Surgical Receives FDA 510(k) Clearance for Second Generation Anovo(R) Robotic Platform, Introducing Haptic Feedback and Dual-Mode Articulation
Devices Surgery FDA
 HSMN NewsFeed - 8 Nov 2024
FDA Advisory Panel Votes in Favor of IceCure's ProSense(R) Cryoablation Benefit-Risk Profile in Early-Stage Low Risk Breast Cancer
Devices Oncology FDA
 HSMN NewsFeed - 6 Nov 2024
I-Mab Appoints Sean Fu, PhD, MBA, as Chief Executive Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 4 Nov 2024
Boston Scientific Announces Agreement to Acquire Cortex, Inc.
Devices Cardiology Mergers & Acquisitions
 HSMN NewsFeed - 31 Oct 2024
Lipocine Announces Distribution and License Agreement with SPC Korea to Commercialize TLANDO(R) in South Korea
Biopharmaceuticals Licensing Distribution
 HSMN NewsFeed - 30 Oct 2024
FDA Grants Orphan Drug Designation to Capsida Biotherapeutics for Potential Treatment of STXBP1 Developmental and Epileptic Encephalopathy
Biopharmaceuticals FDA
 HSMN NewsFeed - 28 Oct 2024
Zimmer Biomet to Debut New Z1(TM) Femoral Hip System and Clinical Data on G7(R) Acetabular System at 2024 AAHKS Annual Meeting
Devices Orthopaedic Product Launch
 HSMN NewsFeed - 25 Oct 2024
Lilly's EBGLYSS(TM) (lebrikizumab-lbkz) Demonstrated Meaningful Improvement in Skin Clearance and Itch Relief in the Majority of Patients with Moderate-To-Severe Atopic Dermatitis Who Discontinued Dupilumab
Biopharmaceuticals Dermatology
 HSMN NewsFeed - 24 Oct 2024
Pillar Biosciences Receives CPT(R) Code for FDA Approved oncoReveal(TM) CDx Pan-Cancer Solid tumor IVD Kit
Diagnostics Oncology Reimbursement
 HSMN NewsFeed - 21 Oct 2024
Kyverna Therapeutics Appoints Mert Aktar to its Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 18 Oct 2024
CHMP Maintains Negative Opinion on Translarna(TM) Reexamination
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 17 Oct 2024
MolecuLight's Fluorescence Imaging: A Game-Changer for Bedside Biofilm Detection
Devices Wound Care
 HSMN NewsFeed - 15 Oct 2024
Accure Acne Announces New FDA Clearance for the Long-Term Treatment of Acne
Devices Dermatology FDA
 HSMN NewsFeed - 10 Oct 2024
Johnson & Johnson MedTech Launches VOLT(TM) Plating System
Devices Orthopaedic Product Launch
 HSMN NewsFeed - 9 Oct 2024
Inspira(TM) Announces Development of New Disposable Kit with Built-In Performance Monitoring Mechanism
Devices
 HSMN NewsFeed - 8 Oct 2024
BTL's Emsculpt Neo Secures FDA Clearance for Treating Medical Diseases and Conditions, Expanding Market Reach
Devices FDA
 HSMN NewsFeed - 7 Oct 2024
ALK Announces U.S. FDA Approval of New AccuTest(TM) Allergy Skin Testing Devices for Optimized Allergy Testing and Diagnosis
Diagnostics FDA
 HSMN NewsFeed - 4 Oct 2024
Voluntary Recall Notifying Medtronic Insulin Pump Users of Potential Risks of Shortened Pump Battery Life
Devices Drug Delivery Product Recall
 HSMN NewsFeed - 3 Oct 2024
Avidity Biosciences Announces FDA Removed Partial Clinical Hold on Delpacibart Etedesiran (del-desiran/AOC 1001)
Biopharmaceuticals FDA
 HSMN NewsFeed - 2 Oct 2024
Kedrion and Biotest complete long-term Exclusive Distribution Agreement for Yimmugo(R) in the US
Biopharmaceuticals Distribution
 HSMN NewsFeed - 27 Sep 2024
Boston Scientific Receives Japanese Regulatory Approval for the FARAPULSE(TM) Pulsed Field Ablation System
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 25 Sep 2024
Medtronic Expands AiBLE(TM) Spine Surgery Ecosystem with New Technologies and Siemens Healthineers Partnership
Devices Neurosurgery Surgery Product Launch
 HSMN NewsFeed - 25 Sep 2024
Heron Therapeutics Announces FDA Approval of the Prior Approval Supplement Application for ZYNRELEF(R) Vial Access Needle ("VAN")
Devices Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 20 Sep 2024
Stryker Completes Acquisition of NICO Corporation, Expanding Minimally Invasive Solutions for Brain Tumor Removal and Stroke Care
Devices Neurosurgery Mergers & Acquisitions
 HSMN NewsFeed - 19 Sep 2024
FDA Declines to Approve Vanda's Marketing Application for Tradipitant in Gastroparesis
Biopharmaceuticals FDA
 HSMN NewsFeed - 18 Sep 2024
Accord BioPharma, Inc. Announces U.S. Food & Drug Administration Approval of 420mg Strength of HERCESSI(TM) (trastuzumab-strf), a biosimilar to Herceptin(R) (trastuzumab), for the Treatment of Several Forms of HER2-Overexpressing Cancer
Biopharmaceuticals Generics Oncology FDA
 HSMN NewsFeed - 17 Sep 2024
Boston Scientific Receives FDA Approval for Expanded Indication of INGEVITY(TM)+ Pacing Leads to Include Conduction System Pacing of the Left Bundle Branch Area
Devices Cardiology FDA
 HSMN NewsFeed - 16 Sep 2024
Penumbra Receives CE Mark for Computer Assisted Vacuum Thrombectomy Technologies - Lightning Flash(TM) 2.0 and Lightning Bolt(TM) 7 - in Europe
Devices Interventional Regulatory
 HSMN NewsFeed - 11 Sep 2024
Breg, Inc. Announces Organizational Leadership Changes
Devices Personnel
 HSMN NewsFeed - 10 Sep 2024
Solventum Launches All-In-One, Extended-Wear Wound Dressing for V.A.C.(R) Therapy
Devices Wound Care Product Launch
 HSMN NewsFeed - 9 Sep 2024
Lilly appoints Lucas Montarce as executive vice president and chief financial officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 5 Sep 2024
Pfizer Appoints Elif Aral as Regional President for the Middle East, Russia & Africa
Biopharmaceuticals Personnel
 HSMN NewsFeed - 4 Sep 2024
Vesalio launches pVasc Thrombectomy System in the U.S. for peripheral occlusions
Devices Interventional Product Launch
 HSMN NewsFeed - 3 Sep 2024
Iridium Network becomes first center in the world to use RayCare and TrueBeam to treat a patient
Devices Oncology
 HSMN NewsFeed - 30 Aug 2024
Sanyou Bio Launches Comprehensive Monkeypox Product Line
Biopharmaceuticals Product Launch
 HSMN NewsFeed - 29 Aug 2024
Expanse Medical Welcomes Jeff Hopkins as CEO and Board Member of its Spin-Off, FlowPhysix
Devices Interventional Personnel
 HSMN NewsFeed - 28 Aug 2024
Neuros Medical Receives FDA Approval for the Altius(R) Direct Electrical Nerve Stimulation System
Devices FDA
 HSMN NewsFeed - 27 Aug 2024
Endo Announces CEO Transition
Biopharmaceuticals Personnel
 HSMN NewsFeed - 26 Aug 2024
Quest Diagnostics Completes Acquisition of LifeLabs, Enhancing Access to Diagnostic Innovation
Diagnostics Mergers & Acquisitions
 HSMN NewsFeed - 22 Aug 2024
Stratus Medical Announces Exclusive Distribution Agreement with Edge Medical for the United Kingdom
Devices Distribution
 HSMN NewsFeed - 20 Aug 2024
Pathalys Pharma Secures $105 Million Series B Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 20 Aug 2024
RYBREVANT(R) (amivantamab-vmjw) Plus LAZCLUZE(TM) (lazertinib) Approved in the U.S. as a First-line Chemotherapy-free Treatment for Patients with EGFR-mutated Advanced Lung Cancer
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 19 Aug 2024
Visiox Pharmaceuticals, Inc. Announces Transformative Merger with Ocuvex Therpeutics, Inc.
Biopharmaceuticals Ophthalmology Mergers & Acquisitions
 HSMN NewsFeed - 16 Aug 2024
Lilly Completes Acquisition of Morphic to Improve Outcomes and Expand Options for People Living with Inflammatory Bowel Disease
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 15 Aug 2024
Haemonetics Announces Full Market Release for VASCADE MVP(R) XL Vascular Closure System
Devices Interventional Cardiology Product Launch
 HSMN NewsFeed - 12 Aug 2024
BD Names Michael Feld as President of Life Sciences Segment
Diagnostics Personnel
 HSMN NewsFeed - 8 Aug 2024
Sobi and Apellis announce positive topline results from phase 3 VALIANT study of pegcetacoplan in C3G and primary IC-MPGN
Biopharmaceuticals
 HSMN NewsFeed - 5 Aug 2024
Mallinckrodt Reaches Agreement to Sell Therakos(R) Business to CVC for $925 Million
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 1 Aug 2024
Jade Biosciences Launches with $80 Million to Develop Transformative Therapies for Autoimmune Diseases
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 31 Jul 2024
Stryker completes acquisition of MOLLI Surgical
Devices Surgery Mergers & Acquisitions
 HSMN NewsFeed - 29 Jul 2024
Syndax Announces PDUFA Action Date Extension for Revumenib NDA for Relapsed or Refractory KMT2Ar Acute Leukemia
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 25 Jul 2024
BD, Quest Diagnostics Join Forces to Develop Companion Diagnostics for Cancer, Other Diseases
Diagnostics Oncology
 HSMN NewsFeed - 24 Jul 2024
Hoth Therapeutics Partners with LTS Therapy Systems to Accelerate Novel Alzheimer's Treatment
Biopharmaceuticals Drug Delivery Neurology
 HSMN NewsFeed - 22 Jul 2024
Latigo Biotherapeutics Appoints Nima Farzan as Chief Executive Officer, Positioning Company for Rapid Growth
Biopharmaceuticals Personnel
 HSMN NewsFeed - 19 Jul 2024
Rona Therapeutics Raises $35 Million Series A+ Financing to Advance Innovative Metabolic siRNA Pipeline in Clinic and Next Generation RNA Platforms
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 18 Jul 2024
Tufts Medical Center Becomes First Hospital in Massachusetts to Adopt MOLLI Surgical's Breast Cancer Technology
Devices Surgery
 HSMN NewsFeed - 17 Jul 2024
Alltrna Announces Updates to its Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 12 Jul 2024
Bedal International raises $11 Million to boost growth of its FlexGRIP(R) catheter securement devices
Devices Venture Capital
 HSMN NewsFeed - 11 Jul 2024
Akebia Therapeutics Provides Update on Continued Momentum of Commercial Launch of Vafseo(R) (vadadustat) Tablets
Biopharmaceuticals
 HSMN NewsFeed - 10 Jul 2024
AbbVie Announces Appointment of Roopal Thakkar, M.D. as Executive Vice President, Research & Development and Chief Scientific Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 8 Jul 2024
Lilly to Acquire Morphic to Improve Outcomes for Patients with Inflammatory Bowel Disease
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 28 Jun 2024
AbbVie Receives Positive CHMP Opinion for Epcoritamab (TEPKINLY(R)) for the Treatment of Adults with Relapsed/Refractory Follicular Lymphoma
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 26 Jun 2024
BrainStorm Cell Therapeutics Reaches Alignment with FDA on CMC Aspects of Phase 3b NurOwn(R) Clinical Trial
Regenerative Medicine Neurology FDA
 HSMN NewsFeed - 25 Jun 2024
Halozyme Announces Roche's OCREVUS(R) SC with ENHANZE(R) Receives European Commission Approval for Relapsing and Primary Progressive Multiple Sclerosis
Biopharmaceuticals Neurology Regulatory
 HSMN NewsFeed - 24 Jun 2024
Harmony Biosciences Receives U.S. Food And Drug Administration Approval For Wakix(R) (Pitolisant) In Pediatric Patients With Narcolepsy
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 19 Jun 2024
European Commission grants Sobi(R) Marketing Authorisation for ALTUVOCT(TM) for treatment of haemophilia A
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 18 Jun 2024
Roche receives FDA clearance on its digital pathology solution for diagnostic use
Devices Diagnostics FDA
 HSMN NewsFeed - 17 Jun 2024
Raya Therapeutic Announces Supportive Clinical Results of Fasudil (RT1968) in ALS Patients
Biopharmaceuticals Neurology
 HSMN NewsFeed - 14 Jun 2024
TALVEY(R) (talquetamab-tgvs) Demonstrates Highly Durable, Longer-Term Responses in Patients with Relapsed or Refractory Multiple Myeloma
Biopharmaceuticals Oncology
 HSMN NewsFeed - 12 Jun 2024
REGENXBIO Announces Leadership Transition
Biopharmaceuticals Personnel
 HSMN NewsFeed - 11 Jun 2024
Amber Implants Completes Enrollment of First-In-Human Clinical Trial of its VCFix(R) Spinal System
Devices Orthopaedic Neurosurgery
 HSMN NewsFeed - 7 Jun 2024
DePuy Synthes Receives 510(k) FDA Clearance of the VELYS(TM) Robotic-Assisted Solution for Use in Unicompartmental Knee Arthroplasty Procedures
Devices Orthopaedic FDA
 HSMN NewsFeed - 6 Jun 2024
I-Mab Appoints Phillip Dennis, MD, PhD, as Chief Medical Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 5 Jun 2024
Lilly announces departure of Anat Ashkenazi, chief financial officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 3 Jun 2024
BD to Acquire Edwards Lifesciences' Critical Care Product Group for $4.2 Billion to Expand Smart Connected Care Solutions and Become an Advanced Monitoring Technology Leader
Devices Monitoring Acquisitions
 HSMN NewsFeed - 31 May 2024
SIFI Receives Positive CHMP Opinion for Akantior(R) (polihexanide 0.08%) in Acanthamoeba Keratitis
Biopharmaceuticals Ophthalmology Regulatory
 HSMN NewsFeed - 28 May 2024
Terumo Cardiovascular Announces 510(K) Clearance for the CDI OneView(TM) Monitoring System
Devices Monitoring FDA
 HSMN NewsFeed - 28 May 2024
IDEAYA Biosciences Appoints Daniel A. Simon as Chief Business Officer to Lead Corporate Strategy and Business Development
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 27 May 2024
Roche And Hitachi High-Tech Extend their 46-Year Partnership, Paving the Way for Further Breakthroughs in Diagnostic Testing
Diagnostics
 HSMN NewsFeed - 22 May 2024
Virtual-Ports Receives CE Certification for Revolutionary Surgical Products
Devices Surgery Regulatory
 HSMN NewsFeed - 21 May 2024
Biocon Biologics Obtains U.S. FDA Approval for Biosimilar Aflibercept for Yesafili(TM). Enters U.S. Ophthalmology Market
Biopharmaceuticals Generics Ophthalmology FDA
 HSMN NewsFeed - 20 May 2024
Shoulder Innovations Launches InSet(TM) 95 Humeral Stem
Devices Orthopaedic Product Launch
 HSMN NewsFeed - 15 May 2024
Compugen Appoints David Silberman as Chief Financial Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 13 May 2024
CereVasc Announces $70 Million Series B Financing to Advance its Novel eShunt(R) System for the Treatment of Normal Pressure Hydrocephalus
Devices Neurosurgery Venture Capital
 HSMN NewsFeed - 6 May 2024
Scientia Vascular Announces FDA approvals for New Line of Microfabricated Neurovascular Catheters
Devices Interventional Neurology FDA
 HSMN NewsFeed - 2 May 2024
PreludeDx Welcomes Dr. Pat Whitworth as Chief Medical Officer to Drive Expansion of Precision Diagnostics
Diagnostics Oncology Personnel
 HSMN NewsFeed - 1 May 2024
MagVenture Announces Collaboration with Magnus Medical to Bring the SAINT(R) Neuromodulation System to Market
Devices Neurology
 HSMN NewsFeed - 29 Apr 2024
Labcorp Receives FDA Approval for First Companion Diagnostic for Use with Pfizer's Newly Approved Gene Therapy to Treat Patients with Hemophilia B
Biopharmaceuticals Diagnostics FDA
 HSMN NewsFeed - 29 Apr 2024
Repertoire(R) Immune Medicines and Bristol Myers Squibb Announce Multi-Year Strategic Collaboration to Develop Tolerizing Vaccines for Autoimmune Diseases
Biopharmaceuticals
 HSMN NewsFeed - 26 Apr 2024
Sobi(R) Receives Positive CHMP Opinion Recommending Approval of Efanesoctocog Alfa for Once-Weekly Treatment of Haemophilia A
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 22 Apr 2024
SystImmune, Inc. Appoints Dr. Jie D'Elia as Chief Executive Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 16 Apr 2024
Xstim, Inc. Receives FDA Approval for Xstim(TM) Spine Fusion Stimulator
Devices Neurosurgery Orthopaedic FDA
 HSMN NewsFeed - 15 Apr 2024
Labcorp Announces First-of-Its-Kind Test for Early Indication of Neurodegenerative Diseases and Brain Injuries Using a Blood Draw
Diagnostics Neurology Product Launch
 HSMN NewsFeed - 10 Apr 2024
TORL BioTherapeutics Announces $158 Million Oversubscribed Series B-2 Financing to Advance the Clinical Development of its Novel Antibody-Drug Conjugate (ADC) Oncology Pipeline
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 3 Apr 2024
Kintara Therapeutics and TuHURA Biosciences Enter into Definitive Merger Agreement
Biopharmaceuticals Oncology Mergers & Acquisitions
 HSMN NewsFeed - 2 Apr 2024
NeoImmuneTech Appoints Dr. Luke Oh, Ph.D. as New Chief Executive Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 27 Mar 2024
Medtronic Announces FDA Approval of Newest-Generation Evolut TAVR System for Treatment of Symptomatic Severe Aortic Stenosis
Devices Interventional Cardiology FDA
 HSMN NewsFeed - 26 Mar 2024
Endo Launches Ibuprofen-Famotidine Tablets, Generic Version of DUEXIS(R)
Biopharmaceuticals Generics Product Launch
 HSMN NewsFeed - 25 Mar 2024
Poseida Therapeutics Appoints Syed Rizvi, M.D., as Chief Medical Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 25 Mar 2024
Sirtex Medical Appoints Matt Schmidt as New Chief Executive Officer and Board of Directors Member
Devices Oncology Personnel
 HSMN NewsFeed - 22 Mar 2024
Astellas Receives Positive CHMP Opinion for XTANDI(TM) in Additional Recurrent Early Prostate Cancer Treatment Setting
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 19 Mar 2024
Fusion Pharmaceuticals to be Acquired by AstraZeneca, Accelerating Development of Next-Generation Radioconjugates to Treat Cancer
Biopharmaceuticals Oncology Mergers & Acquisitions
 HSMN NewsFeed - 18 Mar 2024
Syndax Announces Appointment of Steven Closter as Chief Commercial Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 15 Mar 2024
Delcath Systems Announces $7 Million Private Placement
Biopharmaceuticals Drug Delivery Oncology Venture Capital
 HSMN NewsFeed - 11 Mar 2024
PulseCath Achieves MDR CE Certification for iVAC 2L, Paving the Way for Complex High-Risk Percutaneous Coronary Interventions
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 8 Mar 2024
U.S. Food and Drug Administration to Convene Advisory Committee Meeting to Discuss the TRAILBLAZER-ALZ 2 Study of Donanemab
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 7 Mar 2024
BioMarin Announces Appointment of Cristin Hubbard as Chief Commercial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 5 Mar 2024
ADI Announces U.S. FDA 510(k) Clearance and the Commercial Launch of Sensinel by Analog Devices(TM) Cardiopulmonary Management (CPM) System
Devices Cardiology Monitoring FDA
 HSMN NewsFeed - 5 Mar 2024
Haemonetics Announces Definitive Agreement to Acquire Attune Medical
Devices Mergers & Acquisitions
 HSMN NewsFeed - 4 Mar 2024
Insightec's Groundbreaking Transcranial MR-Guided Focused Ultrasound (MRgFUS) Approved for Additional Reimbursement for Essential Tremor in Germany
Devices Neurology Reimbursement
 HSMN NewsFeed - 4 Mar 2024
Mallinckrodt Announces Appointment of Paul O'Neill as Executive Vice President, Quality & Operations, Specialty Brands
Biopharmaceuticals Personnel
 HSMN NewsFeed - 1 Mar 2024
Mallinckrodt Announces U.S. FDA Approval of Supplemental New Drug Application for Acthar(R) Gel (repository corticotropin injection) Single-Dose Pre-filled SelfJect(TM) Injector
Devices Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 1 Mar 2024
Boston Scientific Receives FDA Approval for the AGENT(TM) Drug-Coated Balloon
Devices Interventional Cardiology FDA
 HSMN NewsFeed - 29 Feb 2024
Spatz Medical Marks Milestone: Spatz3 Adjustable Gastric Balloon Launches in the U.S. in March 2024
Devices Gastroenterology Product Launch
 HSMN NewsFeed - 29 Feb 2024
Spineart Completes Enrollment in the BAGUERA(R)C IDE Trial for Single-Level Cervical Disc Replacement
Devices Orthopaedic Neurosurgery
 HSMN NewsFeed - 27 Feb 2024
Dave Hickey Announces Intent to Retire from BD
Diagnostics Personnel
 HSMN NewsFeed - 27 Feb 2024
Nuvalent Receives U.S. FDA Breakthrough Therapy Designation for NVL-520
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 23 Feb 2024
BrainStorm Cell Therapeutics Submits Special Protocol Assessment (SPA) Request to FDA for Phase 3b Trial of NurOwn(R) in ALS
Regenerative Medicine Neurology FDA
 HSMN NewsFeed - 22 Feb 2024
NeoChord, Inc. Appoints New Chief Executive Officer to Lead Commercialization Efforts and Study Novel First-Line Therapy for Mitral Valve Regurgitation
Devices Cardiology Personnel
 HSMN NewsFeed - 22 Feb 2024
Zimmer Biomet Receives FDA Clearance for ROSA(R) Shoulder System - the World's First Robotic Assistant for Shoulder Replacement Surgery
Devices Orthopaedic FDA
 HSMN NewsFeed - 21 Feb 2024
AbbVie Announces Appointment of Robert A. Michael as Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 20 Feb 2024
Avidity Biosciences Receives FDA Rare Pediatric Disease Designation for AOC 1044 for Treatment of Duchenne Muscular Dystrophy in People with Mutations Amenable to Exon 44 Skipping
Biopharmaceuticals FDA
 HSMN NewsFeed - 16 Feb 2024
Fusion Pharmaceuticals Enters into Exclusive Worldwide License Agreement with Heidelberg University and Euratom for Actinium-Based PSMA Targeted Radiotherapy
Biopharmaceuticals Oncology Licensing
 HSMN NewsFeed - 15 Feb 2024
Freenome Raises $254 Million in New Funding to Accelerate its Platform for Early Cancer Detection
Diagnostics Oncology Venture Capital
 HSMN NewsFeed - 14 Feb 2024
Dr. Lisa Johnson-Pratt Joins Aspen Neuroscience as Senior Vice President, Therapeutic Program Lead
Regenerative Medicine Neurology Personnel
 HSMN NewsFeed - 14 Feb 2024
Latigo Biotherapeutics Debuts with $135 Million Series A Financing to Develop Non-Opioid Pain Medicines
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 13 Feb 2024
ProfoundBio Raises $112 Million in Oversubscribed Series B Equity Financing to Advance its Clinical-Stage Antibody-Drug Conjugate (ADC) Pipeline
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 12 Feb 2024
AbbVie Completes Acquisition of ImmunoGen
Biopharmaceuticals Oncology Mergers & Acquisitions
 HSMN NewsFeed - 7 Feb 2024
Innova Vascular Announces Successful Early Commercial Use of Laguna Thrombectomy System(TM) in Patients
Devices Interventional
 HSMN NewsFeed - 6 Feb 2024
Zynex Receives FDA Clearance for its Next Generation NMES Device
Devices FDA
 HSMN NewsFeed - 6 Feb 2024
FDA Clears Groundbreaking Corplex P(TM): The First Human Umbilical Cord-Derived Medical Device
Devices Wound Care FDA
 HSMN NewsFeed - 2 Feb 2024
Tyra Biosciences, Inc. Announces $200 Million Private Placement Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 31 Jan 2024
Labcorp Launches New Test for Risk Assessment and Prognosis of Severe Preeclampsia in Pregnant Women
Diagnostics Product Launch
 HSMN NewsFeed - 30 Jan 2024
BD, Techcyte Announce Strategic Collaboration to Offer AI-Based Digital Cervical Cytology System for Pap Testing
Diagnostics Oncology
 HSMN NewsFeed - 29 Jan 2024
Introducing Sechrist's Innovative eHEAL and 3300HM Hyperbaric Chamber
Devices Product Launch
 HSMN NewsFeed - 25 Jan 2024
Providence Swedish Radiosurgery Center in Seattle Invests in Second Accuray CyberKnife(R) System, a Robotic Delivery Device That Makes Extremely Precise Radiation Treatments Possible in 1-5 Sessions
Devices Oncology
 HSMN NewsFeed - 23 Jan 2024
FDA Grants Breakthrough Device Designation to Amadix´s preventive screening blood test for Colorectal Cancer
Diagnostics Oncology FDA
 HSMN NewsFeed - 22 Jan 2024
CalciMedica Announces Private Placement of up to Approximately $55 Million
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 18 Jan 2024
Cepheid Receives Expanded FDA Clearance with CLIA Waiver for Xpert(R) Xpress MVP
Diagnostics FDA
 HSMN NewsFeed - 15 Jan 2024
NeoImmuneTech Welcomes a New President for its Development and Business
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 10 Jan 2024
Providence Medical Technology Announces FDA Clearance of CAVUX(R) FFS-LX Lumbar Facet Fixation System for 1- and 2-Level Lumbar Spinal Fusion
Devices Neurosurgery Orthopaedic FDA
 HSMN NewsFeed - 8 Jan 2024
Medtronic Diabetes announces world's first approval for MiniMed(TM) 780G System with Simplera Sync(TM) disposable, all-in-one sensor
Devices Monitoring Regulatory
 HSMN NewsFeed - 4 Jan 2024
Lilly Launches End-to-End Digital Healthcare Experience through LillyDirect(TM)
Biopharmaceuticals Product Launch
 HSMN NewsFeed - 2 Jan 2024
Pulnovo Medical Announces PADN Receives FDA HUD Designation and US CMS Medicare Coverage Code and NMPA Approval
Devices Regulatory FDA Reimbursement
 HSMN NewsFeed - 28 Dec 2023
HR Pharmaceuticals, Inc. receives exclusive commercialization rights to Poiesis Medical's Dual Balloon Catheter technology in North America
Devices Licensing
 HSMN NewsFeed - 27 Dec 2023
Lilly Completes Acquisition of POINT Biopharma
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 26 Dec 2023
Amgen Provides Regulatory Update on Status of Lumakras(R) (Sotorasib)
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 18 Dec 2023
NeuExcell's AAV Gene Therapy for Malignant Glioma Granted Orphan Drug Designation by FDA
Regenerative Medicine Neurosurgery Oncology FDA
 HSMN NewsFeed - 15 Dec 2023
CymaBay Submits New Drug Application to FDA for Seladelpar for the Treatment of Primary Biliary Cholangitis
Biopharmaceuticals FDA
 HSMN NewsFeed - 13 Dec 2023
Kyverna Therapeutics Granted FDA Fast Track Designation for KYV-101 in the Treatment of Patients With Refractory Myasthenia Gravis
Biopharmaceuticals FDA
 HSMN NewsFeed - 13 Dec 2023
Triveni Bio Welcomes Jeff Albers and Allison Luo to its Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 11 Dec 2023
Hummingbird Bioscience Strengthens Leadership Team with Appointment of Angèle Maki as Chief Business Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 8 Dec 2023
AMETEK Completes Acquisition of Paragon Medical
Devices Mergers & Acquisitions
 HSMN NewsFeed - 7 Dec 2023
BD Receives FDA 510(k) Clearance for Potentially Transformative Fingertip Blood Collection Device
Devices Diagnostics FDA
 HSMN NewsFeed - 6 Dec 2023
NSite Medical Announces FDA Clearance for Groundbreaking AI-Based Scoliosis Scanning App
Devices FDA
 HSMN NewsFeed - 4 Dec 2023
Sensorium Therapeutics Announces Appointment of Veteran Biotech Executive Alexandra Glucksmann, Ph.D., as CEO as the Company Progresses Toward the Clinic
Biopharmaceuticals Personnel
 HSMN NewsFeed - 30 Nov 2023
BD Launches Advanced Vascular Access Ultrasound System Designed to Improve Clinician Efficiency
Devices Product Launch
 HSMN NewsFeed - 29 Nov 2023
Biolexis Secures $10 Million in Series A Funding to Advance Metabolic Drug Development
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 27 Nov 2023
RTI Surgical Inc. Receives FDA IDE Approval for the Clinical Investigation of Cortiva(R) Allograft Dermis in Breast Reconstruction
Devices Surgery FDA
 HSMN NewsFeed - 24 Nov 2023
Novartis Issues Voluntary US Nationwide Recall of Two Lots of Sandimmune(R) Oral Solution (cyclosporine oral solution, USP), 100 mg/mL due to Crystallization
Biopharmaceuticals Product Recall
 HSMN NewsFeed - 21 Nov 2023
BD Names Dr. Ronald Silverman as Chief Medical Officer
Devices Diagnostics Personnel
 HSMN NewsFeed - 17 Nov 2023
Novavax Makes Changes to Executive Leadership Team to Enhance Focus on Delivery of Strategic Priorities
Biopharmaceuticals Personnel
 HSMN NewsFeed - 10 Nov 2023
Mirati Therapeutics Receives Positive Opinion from CHMP for KRAZATI (adagrasib) as a Targeted Treatment Option for Patients with Advanced Non-Small Cell Lung Cancer (NSCLC) with a KRASG12C Mutation Following a Re-Examination Procedure
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 10 Nov 2023
EU Approval of AAV5 DetectCDx(TM) Provides Access to Companion Diagnostic for Hemophilia A Gene Therapy
Diagnostics Regulatory
 HSMN NewsFeed - 8 Nov 2023
Recor Medical and Otsuka Medical Devices Announce First FDA-Approved Renal Denervation System for the Treatment of Hypertension
Devices Cardiology FDA
 HSMN NewsFeed - 7 Nov 2023
Johnson & Johnson MedTech Provides Details and Timeline for General Surgery Robot
Devices Surgery FDA
 HSMN NewsFeed - 6 Nov 2023
NeuroBo Pharmaceuticals Strengthens Board of Directors with the Appointment of James P. Tursi, M.D.
Biopharmaceuticals Personnel
 HSMN NewsFeed - 2 Nov 2023
BD Advances "One-Stick Hospital Stay" Vision with Launch of Next-Generation Needle-Free Blood Draw Technology
Devices FDA Product Launch
 HSMN NewsFeed - 31 Oct 2023
FDA Approves Novartis Cosentyx(R) as the First New Biologic Treatment Option for Hidradenitis Suppurativa Patients in Nearly a Decade
Biopharmaceuticals FDA
 HSMN NewsFeed - 31 Oct 2023
Zynex Announces Review of Strategic Alternatives
Devices Monitoring
 HSMN NewsFeed - 24 Oct 2023
BrainStorm Cell Therapeutics Announces Strategic Realignment Prioritizing NurOwn(R) for the Treatment of ALS
Regenerative Medicine Neurology
 HSMN NewsFeed - 23 Oct 2023
Medtronic receives FDA approval for extravascular defibrillator to treat abnormal heart rhythms, sudden cardiac arrest
Devices Cardiology FDA
 HSMN NewsFeed - 18 Oct 2023
BrainStorm Cell Therapeutics to Meet with US FDA to Discuss Development Plan for NurOwn as a Treatment of ALS
Regenerative Medicine Neurology
 HSMN NewsFeed - 16 Oct 2023
Cordis issues statement on the CMS announcement to expand coverage of carotid stenting
Devices Interventional Reimbursement
 HSMN NewsFeed - 6 Oct 2023
Amgen Completes Acquisition of Horizon Therapeutics plc
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 5 Oct 2023
AbbVie Exercises Exclusive Right to Acquire Mitokinin, Further Strengthening Neuroscience Pipeline
Biopharmaceuticals Neurology Mergers & Acquisitions
 HSMN NewsFeed - 4 Oct 2023
Rarebase Names Chris Moxham as Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 3 Oct 2023
Amber Implants Announces Start of Clinical Trial with VCFix(R) Spinal System
Devices Neurosurgery Orthopaedic
 HSMN NewsFeed - 2 Oct 2023
MedAlliance Acquired by Cordis for up to USD 1.135 Billion
Devices Interventional Cardiology Mergers & Acquisitions
 HSMN NewsFeed - 26 Sep 2023
Gensco(R) Pharma Announces RizaFilm(R) Commercialization Update in the United States
Biopharmaceuticals Drug Delivery Product Launch
 HSMN NewsFeed - 21 Sep 2023
Medtronic Diabetes announces CE Mark for new Simplera(TM) CGM with disposable all-in-one design
Devices Endocrinology Regulatory
 HSMN NewsFeed - 20 Sep 2023
IceCure Medical Receives FDA Response to De Novo Classification Request for Breast Cancer
Devices FDA
 HSMN NewsFeed - 19 Sep 2023
Boston Scientific Announces Agreement to Acquire Relievant Medsystems, Inc.
Devices Mergers & Acquisitions
 HSMN NewsFeed - 18 Sep 2023
MiRus(R) Announces Launch of Molybdenum-Rhenium Low Profile ATLAS(TM) MoRe(R) Foot and Ankle Plating System
Devices Orthopaedic Product Launch
 HSMN NewsFeed - 12 Sep 2023
Protalix BioTherapeutics Appoints Eliot Richard Forster, Ph.D. as Chairman of its Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 8 Sep 2023
Citius Pharmaceuticals, Inc. Receives Regulatory Guidance from the U.S. Food and Drug Administration (FDA) regarding the Planned Resubmission of the BLA for LYMPHIR(TM)
Biopharmaceuticals Oncology FDA
Return to NewsFeed  

 Additional items found! 500

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 500 additional stories matching:
MMI
(Password required)
FindReps - screen and connect with rep candidates anonymously, in real time.

FindReps: Screen and connect with Medical Sales Rep candidates (Direct Reps and Independents) – anonymously, in real time.


RepJobs - Job Opportunities for Direct Sales Reps and New Product Lines for Independents!

RepJobs: Job Opportunities for Direct Sales Reps and New Product Lines for Independents!